メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
藤田医科大学 ホーム
English
日本語
ホーム
プロファイル
研究部門
研究成果
専門知識、名前、または所属機関で検索
Scopus著者プロファイル
高橋 雅英
研究統括監理室
h-index
18991
被引用数
72
h 指数
Pureの文献数とScopusの被引用数に基づいて算出されます
1981 …
2025
年別の研究成果
概要
フィンガープリント
ネットワーク
研究成果
(342)
類似のプロファイル
(6)
フィンガープリント
Masahide Takahashiが活動している研究トピックを掘り下げます。このトピックラベルは、この研究者の研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Biochemistry, Genetics and Molecular Biology
Receptor Tyrosine Kinase
100%
Mouse
98%
Tyrosine
75%
Glial Cell Line-Derived Neurotrophic Factor
73%
Tyrosine Kinase
73%
Fibroblast
69%
Phosphotransferase
66%
Kinase
66%
Proto Oncogene
63%
Cancer Cell
55%
Actin
49%
Cell Migration
46%
Signal Transduction
43%
Cysteine
43%
Surface Property
37%
Dimerization
32%
RET Proto-Oncogene
30%
Enhancer Region
28%
C-Terminus
26%
Eicosanoid Receptor
26%
Transfection
26%
Enzyme
25%
Actin-Binding Protein
24%
Germline Mutation
24%
Transgenic Mouse
24%
Cytoskeleton
24%
Oncogene
23%
Serine
22%
Phosphoinositide 3-Kinase
21%
Amino Acids
21%
N-Terminus
21%
Epidermal Growth Factor Receptor
21%
Isoform
21%
Codon
20%
Stem Cell
20%
Disulfide
20%
Cadherin
20%
Promoter Region
19%
Cell Motility
19%
Tumor Progression
18%
Exon
18%
Angiogenesis
18%
Oncogene Ret
16%
Intravenous Immunoglobulin
16%
Filopodia
16%
Point Mutation
16%
Carcinogenesis
15%
Stem Cell Marker
14%
Wnt Signaling Pathway
14%
Glycoprotein
14%
Medicine and Dentistry
Neoplasm
46%
Proto Oncogene
40%
Cadmium 109
39%
Malignant Neoplasm
34%
Cancer Cell
32%
Transgenic Mouse
29%
Protein Tyrosine Kinase
27%
Glial Cell Line Derived Neurotrophic Factor
26%
Cancer Associated Fibroblast
25%
Multiple Endocrine Neoplasia
25%
Disease
23%
Oncogene
21%
Lung Cancer
20%
Papillary Thyroid Cancer
19%
Cell Migration
19%
Stroma
18%
Multiple Endocrine Neoplasia Type 2b
18%
Protein Ret
17%
Thyroid Cancer
17%
Breast Cancer
16%
Nodular Melanoma
16%
Hirschsprung's Disease
16%
Signal Transduction
15%
Thyroid Medullary Carcinoma
15%
Actin Binding Protein
15%
Tumor Progression
15%
Actin
15%
Melanocytic Tumor
15%
Tumor Cell
13%
Cytoskeleton
12%
Multiple Endocrine Neoplasia Type 2
12%
Pancreas Cancer
12%
Tumor Invasion
11%
Oncogene Ret
11%
Genetic Transfection
11%
Fibroblast
11%
Phosphotransferase
11%
Kidney Hypoplasia
11%
Ganglioglioma
11%
Immunotherapy
11%
Stem Cell
11%
Neurotropic Agent
11%
Fibrosis
11%
Finger
11%
Point Mutation
10%
Intestine Innervation
10%
Exon
10%
Metastatic Carcinoma
10%
Biological Marker
10%
Receptor
9%
Keyphrases
Multiple Endocrine Neoplasia Type 2 (MEN2)
43%
RET Proto-oncogene
42%
CD109
33%
Glial Cell Line-derived Neurotrophic Factor
31%
Oncogene
29%
RET Tyrosine Kinase
25%
Girdin
22%
Hirschsprung Disease
22%
Transforming Activity
22%
Tyrosine
20%
Tyrosine Kinase
19%
Kinase Activity
18%
Kinase Domain
17%
Tyrosine Phosphorylation
17%
Tyrosine Residue
17%
Oncogene Products
17%
Pancreatic Cancer
16%
RET Signaling
15%
MEN2B
15%
Phosphoinositide 3-kinase (PI3K)
15%
Signaling Pathway
14%
Neurotrophic Factors
14%
Mouse Mammary Tumor Virus
14%
Neuroblastoma Cells
13%
Complementary DNA (cDNA)
12%
Sandwich Immunoassay
12%
Amino Acids
12%
Associated Proteins
11%
Cancer-associated Fibroblasts
11%
RET Kinase
11%
Superactivation
11%
Thyroid Cancer
11%
Prognostic Diagnosis
11%
Pharmacologic Conversion
11%
Pro-tumor
11%
Endothelial Progenitor Cells
11%
C-Ret
10%
Dimerization
10%
Tumor Cells
10%
Transgenic Mice
10%
Expression Level
10%
Tumor
10%
Germline mutation
10%
SK-N-MC Cells
10%
Extracellular Domain
9%
Amino
9%
Phenylalanine
9%
Medullary Thyroid Carcinoma
8%
Phosphotyrosine Binding Domains
8%
Cysteine
8%
